EDAP-TMS
Lithotritie extracorporelle par EDAP TMS

Visio-Track

Lithotritie stéréotaxique. Système de localisation "Freeline". Un système sans contrainte pour garantir le traitement le plus efficace. Disponible sur toute la gamme Sonolith®.

EDAP-TMS
Ultrasons focalisés de haute intensité

Focal One®

Focal One® répond à tous les critères pour une thérapie focale idéale : fusion d'images IRM, approche chirurgicale non-invasive, énergie thérapeutique précise et efficace et validation de la zone traitée par IRM le lendemain du traitement.

News
EDAP-TMS
mars 3, 2021
EDAP TMS, the global leader in robotic energy-based therapies, announces today that the company has selected Medical Technology Partners (MTP) and Argenta Advisors, two leading reimbursement consultancies, to further expand coverage, accelerate market access and secure future payment rates for the company’s Focal One high intensity focused ultrasound (HIFU) procedure in the US. The announcement follows the establishment of a Category 1 CPT code, and physician reimbursement for HIFU, that went into effect on January 1, 2021. Read more
EDAP-TMS
févr. 18, 2021
Marc Oczachowski is Chairman of the Board and Chief Executive Officer of EDAP TMS, a high-tech medical company which develops, manufactures markets minimally invasive therapeutic ultrasound solutions for urology, tumor removal, localized prostate cancer, and infectious diseases. Read more
EDAP-TMS
janv. 14, 2021
Positive 24 month interim results of French Urology Association (AFU) sponsored clinical trial study comparing HIFU to radical prostate surgery: results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP). Read more
EDAP-TMS
déc. 17, 2020
EDAP TMS and #HIFU users are handling the situation with COVID-19 when elective procedures are currently being put on-hold. Read more
EDAP-TMS
déc. 9, 2020
U.S. Centers for Medicare and Medicaid Services (CMS) has issued its final rules establishing, for the first time, a Category 1 CPT code which facilitates reimbursement for the ablation of malignant prostate tissue with HIFU technology, effective January 1, 2021. Read more

EDAP-TMS
Lithotritie extracorporelle et laser

Lithotritie extracorporelle

EDAP TMS, un des leaders mondiaux sur la lithotritie extracorporelle, propose une gamme complète de solutions non-invasives et mini-invasives qui couvre toute l'étendue des indications du calcul urinaire.

EDAP-TMS
Ultrasons focalisés de haute intensité

Ultrasons pour le cancer de la prostate

EDAP TMS propose une alternative aux thérapies radicales standard telles que la chirurgie ou la radiothérapie, non-invasive et basée sur les ultrasons focalisés ...